Enanta Pharmaceuticals
ENTA
#7451
Rank
HK$3.28 B
Marketcap
HK$113.66
Share price
3.62%
Change (1 day)
82.57%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Net assets

Net assets on the balance sheet as of June 2025 : HK$0.61 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has HK$0.61 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Enanta Pharmaceuticals - Net assets on balance sheet (from 2011 to 2025)

Net assets by year

Year Net assets Change
2024-09-30$HK$1.00 B-41%
2023-09-30$HK$1.69 B-32.71%
2022-09-30$HK$2.52 B-18.89%
2021-09-30$HK$3.11 B-11.92%
2020-09-30$HK$3.53 B-2.61%
2019-09-30$HK$3.62 B17.63%
2018-09-30$HK$3.08 B30.8%
2017-09-30$HK$2.35 B12.53%
2016-09-30$HK$2.09 B14.4%
2015-09-30$HK$1.83 B58.56%
2014-09-30$HK$1.15 B34.72%
2013-09-30$HK$0.85 B151.54%
2012-09-30$HK$0.34 B99.14%
2011-09-30$HK$0.17 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AbbVie
ABBV
-HK$20.24 Billion-3,378.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$617.13 B 99,897.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$134.81 B 21,745.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$404.07 B 65,373.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$144.79 B 23,361.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$348.37 B 56,348.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland